In a multicenter study of anti-LRP4/agrin antibody-positive MG, it was revealed that 15% of DNMG is LAPMG and that LAPMG has more severe symptoms and a longer duration of disease (Rivner et al., 2020). Here, LRP4 is linked to myasthenia gravis.